[Federal Register: March 18, 2002 (Volume 67, Number 52)]
[Notices]               
[Page 12049]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18mr02-134]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 9, 2001, and published in the Federal 
Register on August 10, 2001, (66 FR 42239), Lilly Del Caribe, Inc., 
Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 
00680, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as bulk manufacturer of 
dextropropoxpyhene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to bulk manufacture product for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 832(a) and 
determined that the registration of Lilly Del Caribe, Inc., to 
manufacturer dextropropoxphene is consistent with the public interest 
at this time. DEA has investigated Lilly Del Caribe, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. This investigation included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0. 104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basis class of controlled 
substances listed above is granted.

    Dated: March 7, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-6323 Filed 3-15-02; 8:45 am]
BILLING CODE 4410-09-M